Retracted: Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration

Salomé Abdellaoui, Matthieu Gregoire, Marie Dubert, Geoffrey Cheminet, Jean-Benoît Arlet, Emmanuel Lafont

Open source

DOI
10.1093/jac/dkad013
Published
2023-01-26
Container
Journal of Antimicrobial Chemotherapy
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkad013,
  title = {Retracted: Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration},
  author = {Salomé Abdellaoui and Matthieu Gregoire and Marie Dubert and Geoffrey Cheminet and Jean-Benoît Arlet and Emmanuel Lafont},
  year = {2023},
  journal = {Journal of Antimicrobial Chemotherapy},
  doi = {10.1093/jac/dkad013},
  url = {https://doi.org/10.1093/jac/dkad013}
}

RIS

TY  - JOUR
TI  - Retracted: Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration
AU  - Salomé Abdellaoui
AU  - Matthieu Gregoire
AU  - Marie Dubert
AU  - Geoffrey Cheminet
AU  - Jean-Benoît Arlet
AU  - Emmanuel Lafont
PY  - 2023
JO  - Journal of Antimicrobial Chemotherapy
DO  - 10.1093/jac/dkad013
UR  - https://doi.org/10.1093/jac/dkad013
ER  - 

APA

Abdellaoui, S., Gregoire, M., Dubert, M., Cheminet, G., Arlet, J., & Lafont, E. (2023). Retracted: Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad013

Source records